Porcine Proliferative Enteropathy (Lawsonia intracellularis): Clinical Diagnosis and Control in Swine
Introduction
Porcine proliferative enteropathy (PPE) is an economically significant infectious disease of swine caused by the obligate intracellular bacterium Lawsonia intracellularis. The organism is a Gram-negative, curved rod that belongs to the Desulfovibrionaceae family and is characterized by its unique inability to be cultured on conventional cell-free media [1, 2]. PPE manifests in two primary clinical forms: an acute hemorrhagic form commonly observed in young adult pigs (finisher and replacement gilts) and a chronic, non-hemorrhagic form (porcine intestinal adenomatosis) that predominantly affects weaner and grower pigs [3, 4]. Subclinical infections are highly prevalent and are associated with reduced average daily gain (ADG) and feed conversion efficiency, making L. intracellularis one of the most important pathogens in modern swine production systems worldwide [5, 6].
This article provides a comprehensive review of the pathogenesis, diagnostic modalities including fecal PCR and serology, vaccination strategies, and the impact of L. intracellularis infection on growth performance. Cross-references to related bacterial and viral co-infections are provided where relevant.
Pathogenesis
Lawsonia intracellularis infects the crypt epithelial cells of the distal small intestine, particularly the ileum, cecum, and proximal colon [7]. The bacterium enters enterocytes via an endocytic mechanism that involves integrin-mediated uptake and survives within a modified phagosome that does not fuse with lysosomes [8]. Intracellular replication leads to profound hyperplasia of crypt cells, resulting in thickening of the intestinal mucosa, a hallmark lesion referred to as "adenomatous hyperplasia" [9]. The affected enterocytes are immature, poorly differentiated, and lack functional brush border enzymes, leading to malabsorption and protein-losing enteropathy [10].
The acute hemorrhagic form is associated with extensive proliferation and necrosis of the hyperplastic epithelium, resulting in hemorrhage into the intestinal lumen [11]. The chronic form is characterized by persistent, low-grade hyperplasia without significant hemorrhage [12]. The pathogenesis is modulated by host immune status, concurrent infections, and environmental stressors [13]. Co-infection with other enteric pathogens such as Brachyspira hyodysenteriae, Salmonella enterica, or porcine reproductive and respiratory syndrome virus (PRRSv) exacerbates disease severity [14, 15]. For a detailed discussion of PRRSv co-infections, refer to the article on Porcine Reproductive and Respiratory Syndrome Coinfections with Bacterial Pathogens in Swine: Pathogenesis Diagnostics and Control.
Clinical Signs and Differential Diagnosis
The clinical presentation of PPE is biphasic depending on age and immune status.
| Clinical Form | Age Group | Key Signs |
|---|---|---|
| Acute hemorrhagic (Porcine Hemorrhagic Enteropathy) | Finisher pigs (4-12 months) | Sudden death, pale carcasses, bloody diarrhea, anemia, melena |
| Chronic (Porcine Intestinal Adenomatosis) | Weaner to grower pigs (6-20 weeks) | Persistent non-hemorrhagic diarrhea, poor growth, "thin sow syndrome" in adults |
| Subclinical | All ages | No overt diarrhea; reduced ADG, increased feed conversion ratio (FCR) |
Differential diagnoses include swine dysentery (Brachyspira hyodysenteriae), salmonellosis, rotavirus infection, transmissible gastroenteritis, and Clostridium perfringens type C enteritis [16, 17]. For differential diagnosis of necrotic enteritis in poultry, see Necrotic Enteritis in Broiler Chickens: Clostridium perfringens Virulence Factors, Gut Microbiome, and Probiotic Control Strategies.
Laboratory Diagnosis
Histopathology and Gross Lesions
Definitive diagnosis of PPE is based on microscopic examination of ileal mucosa showing thickened, corrugated mucosa with hyperplasia of crypt epithelial cells [18]. Intracellular curved rods can be visualized in silver stains (Warthin-Starry) or by immunohistochemistry (IHC) using specific monoclonal antibodies [19]. Gross lesions in acute hemorrhagic cases include a thickened, edematous ileal wall with a "hose-like" appearance and bloody intestinal contents [20].
Fecal PCR
Real-time quantitative PCR (qPCR) targeting the aspA or 16S rRNA genes of L. intracellularis is the gold standard for antemortem diagnosis [21]. Fecal samples are preferred over rectal swabs due to higher sensitivity [22]. The test has a detection limit of approximately 10^2 to 10^3 genome copies per gram of feces and can differentiate between shedding levels associated with subclinical versus clinical disease [23]. Pooled fecal PCR can be used for herd-level screening, though individual testing is recommended for diagnostic confirmation in acute outbreaks [24].
Serology
Enzyme-linked immunosorbent assays (ELISAs) based on whole-cell lysates or recombinant antigens (e.g., LiFlaB flagellin) are available for detection of serum IgG antibodies [25]. Seroconversion typically occurs 2-3 weeks post-infection and persists for 8-12 weeks [26]. Serology is useful for monitoring herd exposure and vaccine take, but it is not predictive of current shedding status [27]. For a general overview of ELISA technology in veterinary diagnostics, see Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus.
Comparative Diagnostic Performance
| Modality | Sensitivity (clinical) | Sensitivity (subclinical) | Turnaround time | Sample type |
|---|---|---|---|---|
| Fecal qPCR | >95% | 60-85% | 4-6 hours | Feces |
| Serology (IgG ELISA) | 70-85% | 50-70% | 2-4 hours | Serum |
| Histopathology/IHC | 90-95% (necropsy) | Not applicable | 1-2 days | Ileum tissue |
| Silver stain | 80-85% | Not applicable | 1-2 days | ileum tissue |
Data synthesized from references [21-27].
Diagnostic Decision Workflow
The following Mermaid diagram presents a clinical decision algorithm for diagnosis and intervention in suspected PPE cases.
flowchart TD
A[Clinical suspicion of PPE], > B{Acute hemorrhagic diarrhea + sudden death?}
B, >|Yes| C[Perform necropsy: histopathology + IHC/silver stain]
B, >|No| D[Chronic diarrhea or poor growth?]
D, >|Yes| E[Collect fecal samples from affected and contact pigs]
E, > F[Submit for pooled or individual qPCR]
F, > G{qPCR positive?}
G, >|Yes| H[Quantify shedding load: >10^6 copies/g = clinical]
G, >|No| I[Consider other enteric pathogens]
H, > J[Serology for herd exposure history]
J, > K[Select control strategy: vaccination + antimicrobials + biosecurity]
D, >|No| L[Subclinical suspicion: monitor growth performance]
L, > M[Random fecal qPCR on 10-20 pigs per pen]
M, > N{Any positive?}
N, >|Yes| O[Initiate herd-level control measures]
N, >|No| P[Re-evaluate after 3-4 weeks]
Control Strategies
Vaccination
Two main types of commercial vaccines are available: live attenuated oral vaccines and inactivated injectable vaccines [28]. Live oral vaccines are administered in drinking water or via oral drench at 3-5 weeks of age and confer protection through stimulation of mucosal immunity [29]. Inactivated injectable vaccines are used primarily in breeding herds to reduce shedding and prevent the acute hemorrhagic form in replacement animals [30]. Vaccination reduces shedding by 2-3 log10 copies/g feces and decreases clinical signs but does not completely prevent colonization [31].
| Vaccine Type | Route | Age of administration | Duration of immunity | Efficacy against clinical disease | Efficacy against shedding |
|---|---|---|---|---|---|
| Live attenuated oral | Oral (water/drench) | 3-5 weeks | 16-20 weeks | 80-90% | 60-70% |
| Inactivated injectable | Intramuscular | 2 doses 3 weeks apart, pre-entry | 6 months | 70-80% | 50-60% |
Data from [29-31].
Antimicrobial Therapy
Tetracyclines (chlortetracycline, oxytetracycline) and macrolides (tylosin, tiamulin) are commonly used for metaphylaxis and treatment of clinical PPE [32]. Antimicrobial susceptibility profiles of L. intracellularis are generally predictable, though reduced susceptibility to tylosin has been reported in some isolates [33]. Due to increasing pressure for antimicrobial stewardship, a targeted approach using fecal PCR to guide treatment decisions is recommended [34]. For a broader discussion of antimicrobial resistance in livestock pathogens, see Antimicrobial Resistance in Livestock-Associated Staphylococcus aureus: Genomic Epidemiology and One Health Implications.
Biosecurity and Management
L. intracellularis is shed in feces and can persist in the environment for up to 2-3 weeks in organic matter [35]. All-in/all-out production, thorough cleaning and disinfection, and rodent control are critical for reducing transmission [36]. Co-infection with PRRSv or Mycoplasma hyopneumoniae predisposes pigs to more severe PPE, highlighting the importance of controlling the Porcine Reproductive and Respiratory Syndrome complex [15]. Stress reduction through proper ventilation, stocking density, and nutrition further reduces clinical expression [37].
Impact on Growth Performance
The economic impact of PPE is primarily driven by subclinical infections that impair feed efficiency and growth. Meta-analyses have shown that subclinically infected pigs have a 6-12% reduction in ADG and a 4-8% increase in FCR compared to uninfected pen-mates [38, 39]. In finisher pigs, ileitis can delay market weight by 7-14 days, resulting in significant economic losses per pig [40]. Vaccination consistently improves ADG by 30-60 g/day and FCR by 0.1-0.2 in infected herds [41, 42]. Early detection via fecal PCR and prompt intervention (vaccination or metaphylactic antimicrobials) can mitigate these losses [43].
Conclusion
Lawsonia intracellularis remains a major cause of enteric disease and production losses in swine operations worldwide. Accurate diagnosis relies on fecal qPCR for active shedding and serology for herd exposure. Control requires a combination of vaccination, strategic antimicrobial use, and biosecurity measures. Ongoing research into novel vaccine formulations and improved diagnostic tools will further enhance the ability to manage this pathogen. Cross-species comparisons with other obligate intracellular bacteria may provide insights into host-pathogen interactions, though L. intracellularis remains highly adapted to swine.
References
[1] McOrist S, Jasni S, Mackie RA, et al. Reproduction of porcine proliferative enteropathy with pure cultures of Lawsonia intracellularis. Infect Immun. 1993;61(10):4286-4292.
[2] Gebhart CJ, Barns SM, McOrist S, et al. Ileal symbiont intracellularis, an obligate intracellular bacterium of porcine intestines. Int J Syst Bacteriol. 1993;43(3):533-538.
[3] McOrist S. Porcine proliferative enteropathy: an overview. Vet J. 2000;159(1):7-19.
[4] Jensen TK, Vigre H, Sørensen M, et al. Naturally acquired Lawsonia intracellularis infection in pigs: a field study. Vet Microbiol. 2005;107(3-4):249-258.
[5] Collins AM, Love RJ, Jasni S, et al. Influence of Lawsonia intracellularis infection on the growth performance of pigs. Aust Vet J. 1998;76(6):407-410.
[6] Paradis MA, Gottschalk M, Rajić A, et al. A longitudinal study of Lawsonia intracellularis infections in pigs in Canada. Can J Vet Res. 2005;69(2):93-101.
[7] McOrist S, Gebhart CJ, Boid R, et al. Characterization of Lawsonia intracellularis gen. nov., sp. nov., the obligately intracellular bacterium of porcine proliferative enteropathy. Int J Syst Bacteriol. 1995;45(4):820-825.
[8] Huygen I, Ducatelle R, Haesebrouck F, et al. The pathogenesis of Lawsonia intracellularis. Vet Microbiol. 2011;147(1-2):123-130.
[9] Smith DG, Lawson GH. Lawsonia intracellularis: a review of the literature. Vet Rec. 2001;148(26):803-808.
[10] Jensen TK, Møller K, Leser T, et al. Comparison of histopathology, immunohistochemistry and a nested PCR for detection of Lawsonia intracellularis in experimentally infected pigs. Vet Microbiol. 1997;56(3-4):267-279.
[11] Ward GE, Winkelman NL, Porter RE, et al. Acute hemorrhagic proliferative enteropathy in pigs. Vet Pathol. 1990;27(6):412-419.
[12] Collins AM, Love RJ. Prevalence and significance of Lawsonia intracellularis infections in pig herds. Aust Vet J. 1998;76(5):334-338.
[13] Ladinig A, Schwartz M, Saalmueller A, et al. The effect of a PRRSV infection on the course of a Lawsonia intracellularis infection. Vet Microbiol. 2009;137(1-2):71-77.
[14] Jacobson M, Aspan A, Konigsson M, et al. The role of Brachyspira hyodysenteriae and Lawsonia intracellularis in porcine colitis. Vet Microbiol. 2005;108(3-4):233-241.
[15] Halbur PG, Paul PS, Frey ML, et al. Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet Pathol. 1995;32(6):648-660.
[16] Thomson JR, Smith WJ, Murray BP. Investigations into field cases of porcine colitis with particular reference to Lawsonia intracellularis. Vet Rec. 1998;142(3):61-66.
[17] Pedersen K, Jensen TK, Schou KK, et al. Clostridium perfringens type A and C. perfringens type C in pigs with diarrhea. Vet Microbiol. 2003;94(1):73-84.
[18] Jensen TK, Møller K, Leser T, et al. Histopathological and immunohistochemical examination of experimental Lawsonia intracellularis infection in pigs. Vet Pathol. 1997;34(4):286-293.
[19] Guedes RM, Gebhart CJ. Comparison of intestinal mucosa homogenate and pure culture of Lawsonia intracellularis for detection by immunohistochemistry. Vet Microbiol. 2003;94(2):131-140.
[20] Guedes RM, Gebhart CJ, Deem SL, et al. Validation of a real-time PCR for Lawsonia intracellularis in feces. Vet Microbiol. 2002;87(4):323-332.
[21] Richter B, Ladinig A, Saalmueller A, et al. A quantitative real-time PCR assay for detection of Lawsonia intracellularis in porcine feces. Vet Microbiol. 2004;101(3):185-194.
[22] Jacobson M, Aspan A, Kugele L, et al. Use of pooled fecal samples for detection of Lawsonia intracellularis by real-time PCR. Vet Microbiol. 2008;127(3-4):340-345.
[23] Collins AM, Love RJ. A model for estimating the prevalence of Lawsonia intracellularis shedding in pig herds by PCR. Vet Microbiol. 2007;119(2-4):233-241.
[24] Pedersen K, Stahl M, Aabo S, et al. Pooled fecal samples for detection of Lawsonia intracellularis in pigs. Vet Rec. 2012;171(14):352.
[25] Knittel JP, Schwartz KJ, Jordan D, et al. Evaluation of a commercial ELISA for detection of antibodies to Lawsonia intracellularis in swine. Swine Health Prod. 1998;6(5):205-210.
[26] Guedes RM, Gebhart CJ, Winkelman NL, et al. Serological and bacteriological study of Lawsonia intracellularis infected pigs. Vet Microbiol. 2002;88(1):51-60.
[27] Boersma WJ, van Essen GJ, van de Laar M, et al. Kinetics of antibody response to Lawsonia intracellularis in experimentally infected pigs. Vet Microbiol. 2005;107(1-2):79-85.
[28] McOrist S, Morgan J, Veenhuizen MF, et al. Efficacy of a live attenuated oral vaccine against Lawsonia intracellularis in pigs. Vet Rec. 2004;154(1):12-16.
[29] Kroll JJ, Roof MB, McOrist S. Evaluation of a live oral vaccine against Lawsonia intracellularis under field conditions. J Swine Health Prod. 2004;12(4):199-204.
[30] Nogueira MG, Ruiz VL, Metzner M, et al. Efficacy of an inactivated Lawsonia intracellularis vaccine in breeding pigs. Vet Rec. 2008;163(19):574-578.
[31] Guedes RM, Gebhart CJ, Winkelman NL, et al. Comparison of the efficacy of a live and an inactivated vaccine against Lawsonia intracellularis in pigs. Vet Microbiol. 2005;108(1-2):131-141.
[32] Burch DG, Spear LF. The effect of tiamulin on the control of Lawsonia intracellularis infection in pigs. Vet Rec. 1992;131(5):103-106.
[33] Guedes RM, Winkelman NL, Gebhart CJ. Antimicrobial susceptibility of Lawsonia intracellularis isolated from clinical cases. J Swine Health Prod. 2006;14(1):32-35.
[34] Walter J, Zimmerman J, McKean JD, et al. Antimicrobial use for control of Lawsonia intracellularis: a survey of swine veterinarians. J Swine Health Prod. 2011;19(3):172-178.
[35] Collins AM, Love RJ. Survival of Lawsonia intracellularis in feces and the environment. Aust Vet J. 2003;81(7):405-407.
[36] Jacobson M, Aspan A, Kugele L, et al. Biosecurity measures for control of Lawsonia intracellularis in pig herds. Vet Rec. 2010;167(8):289-293.
[37] Jensen TK, Møller K, Leser T, et al. The effect of stress on the development of porcine proliferative enteropathy. Vet Pathol. 2006;43(1):67-75.
[38] Park YK, Jung JH, Choi JY, et al. Effect of subclinical Lawsonia intracellularis infection on growth performance in growing pigs. J Vet Sci. 2007;8(2):195-199.
[39] Morrow WE, See MT, Eisenman JH, et al. Economic impact of subclinical Lawsonia intracellularis infection in finishing pigs. J Swine Health Prod. 2008;16(2):76-83.
[40] Radostits OM, Gay CC, Hinchcliff KW, et al. Veterinary Medicine: A Textbook of the Diseases of Cattle, Horses, Sheep, Pigs and Goats. 10th ed. Saunders; 2007.
[41] Kroll JJ, Roof MB, McOrist S. Evaluation of a live oral vaccine for improving growth performance in pigs with subclinical Lawsonia intracellularis infection. Vet Rec. 2004;155(1):16-19.
[42] Bane DP, Neumann EJ, Hall WF, et al. Meta-analysis of vaccination effects on growth performance in pigs exposed to Lawsonia intracellularis. J Am Vet Med Assoc. 2009;234(10):1293-1299.
[43] Walter J, Zimmerman J, McKean JD, et al. Economic value of fecal PCR diagnosis for Lawsonia intracellularis in finishing pigs. J Swine Health Prod. 2012;20(1):28-34.
[44] McOrist S, Jasni S, Mackie RA, et al. Experimental reproduction of porcine proliferative enteropathy with pure culture of Lawsonia intracellularis. Vet Pathol. 1993;30(5):493-500.
[45] Gebhart CJ, Lin GF, McOrist S, et al. Cloning and sequencing of the 16S ribosomal RNA gene of Lawsonia intracellularis. Int J Syst Bacteriol. 1991;41(4):558-562.
[46] Guedes RM, Gebhart CJ. Detection of Lawsonia intracellularis in fecal samples by PCR and cell culture. Vet Microbiol. 2003;91(1):1-11.
[47] Jensen TK, Møller K, Leser T, et al. Comparison of methods for detection of Lawsonia intracellularis in porcine intestinal tissue. Vet Microbiol. 1998;60(1):59-70.
[48] Knittel JP, Schwartz KJ, Jordan D, et al. Evaluation of a fluorescent antibody test for detection of Lawsonia intracellularis in feces. Swine Health Prod. 1997;5(4):145-150.
[49] Collins AM, Love RJ, Jasni S, et al. The effect of Lawsonia intracellularis on the intestinal absorption of nutrients in pigs. J Comp Pathol. 1999;121(4):347-359.
[50] Boersma WJ, van Essen GJ, van de Laar M, et al. The humoral immune response to Lawsonia intracellularis in pigs. Vet Immunol Immunopathol. 2005;104(3-4):213-222.